Management of hepatitis C in patients with chronic kidney disease

doi:10.3748/wjg.v21.i2.408

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 21, Issue 2

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (9790)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-3) series, Tables (1-4) series.

Item

Count

PDF

683

WORD

234

HTML

6060

Figures (1-3)

179

Tables (1-4)

172

Sum=7328

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1189

Download

1273

Sum=2462

Jan 14, 2015 (publication date) through Apr 26, 2024

Times Cited of This Article

Times Cited (29)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Gastroenterol. Jan 14, 2015; 21(2): 408-422
Published online Jan 14, 2015. doi: 10.3748/wjg.v21.i2.408

Open in New Tab Full Size Figure Download Figure

Figure 1 Treatment decision algorithm for hepatitis C virus-infected chronic kidney disease patients under conservative management. ¹Adjusted doses according to eGFR. eGFR: Estimated glomerular filtration rate; CKD: Chronic kidney disease; PEG-IFN: Pegylated interferon.

Open in New Tab Full Size Figure Download Figure

Figure 2 Treatment decision algorithm for hepatitis C virus-infected chronic kidney disease patients under hemodialysis who are candidates for kidney transplantation. ¹By real-time PCR or transcription-mediated amplification; ²APRI, FibroTest or transient hepatic elastography; ³Adjusted doses (see text for details). PEG-IFN: Pegylated interferon; KT: Kidney transplantation; SVR: Sustained virological response; HCV: Hepatitis C virus; KT: Kidney transplantation.

Open in New Tab Full Size Figure Download Figure

Figure 3 Treatment decision algorithm for hepatitis C virus-infected kidney transplantation recipients. ¹Particularly if time after transplantation > 5 years; ²APRI, TX3, FibroTest or transient hepatic elastography; ³Adjusted doses according to eGFR. PEG-IFN: Pegylated interferon; RBV: Ribavirin; eGFR: Estimated glomerular filtration rate.

Citation: Carvalho-Filho RJ, Feldner ACC, Silva AEB, Ferraz MLG. Management of hepatitis C in patients with chronic kidney disease. World J Gastroenterol 2015; 21(2): 408-422
URL: https://www.wjgnet.com/1007-9327/full/v21/i2/408.htm
DOI: https://dx.doi.org/10.3748/wjg.v21.i2.408